Dose-Escalation Study of Azacitidine Followed By High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in High-Risk Acute Myeloid Leukemia (AML)

Category Primary study
JournalBlood
Year 2015
This article has no abstract
Epistemonikos ID: 2c56b40f5a551a2a1f2a6813803ae757c355a6cb
First added on: Feb 19, 2025